Bullboard - Stock Discussion Forum Valeo Pharma Inc T.VPH

Alternate Symbol(s): T.VPH.DB | VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

Add To Watchlist

TSX:VPH - Post Discussion

Valeo Pharma Inc > FIRST QUARTER 2022 RESULTS AND HIGHLIGHTS

View:

Post by Betteryear2 on Mar 24, 2022 6:14pm

FIRST QUARTER 2022 RESULTS AND HIGHLIGHTS

Q1-22 revenues of $4.2 million, up 128% over Q1-21
Q1-22 gross margins of $1.4 million, up 266% over Q1-21
Public reimbursement secured in key provinces for Enerzair, Atectura and Redesca
$25.0 million convertible debenture financing completed

MONTREAL, March 24, 2022 /CNW Telbec/ - Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today reported its financial results for the first quarter ended January 31, 2022.

260